|
<< back to Industry Sectors
Health Care Education & Content |
|
The LES (USA & Canada) HealthCare Sector is pleased to present the first "LES BioPharmaceutical Royalty Rates and Deal Terms Survey". This landmark report is one of the many benefits of LES (USA & Canada) membership and reflects the organization’s objective to provide its members with relevant, cutting edge licensing educational information. We believe you will find this report contains many gems on some of the most important areas of deal making in our industry.
Reserve Your Space at the BIO-LES Advance Business Development Course (to be held October 27 – 29, 2007 in San Francisco) here
When it comes to licensing, are you Certifiable? If so, sign up for the Certified Licensing Professional (CLP) here
Current Healthcare Highlight Article
The Giant Of All Financial Health Care Conferences:
The JP Morgan Health Care Conference
By Ruth Plager
The crush in the hallways of the San Francisco St. Francis Hotel, January 7-10, 2008 at the 26th Annual JP Morgan Health Care Conference is but the tip of the iceberg. Officially, JP Morgan reports 7,462 attendees for the four-day program including presentations by 338 companies, 283 public and 55 private.
The timing of the annual JP Morgan Health Care conference which kicks off the New Year couldn't be better. Everyone is refreshed after the holidays, the San Francisco location coupled with a time slot that isn't competing with any of the other major medical, financial, and business development partnering conferences maximizes attendance, which includes international representation.
All San Francisco hotels and restaurants are packed—with health care networking and dealmaking happening everywhere. The buzz in the conference hallways and in suites all around town focus on deals, deals, more deals, and financing… in every imaginable configuration.
For public companies, or private companies in financing mode, the number of attendees per company range from three to eight—depending on what's needed for coverage of all the pre-scheduled meetings and depending upon the JP Morgan allotment per company. Even the major companies are given a quota of attendees by JP Morgan.
The actual attendance far exceeds the official numbers reported by JP Morgan. As many comment, this is the only financial conference that all the other bankers also attend! Most of the large pharma and biotech companies, as well as VC's, bankers, and law firms with large health care practices have suites in the hotels, with back-to-back off-site meetings scheduled throughout the conference. And many of the companies also host private evening receptions.
How frequently I heard colleagues comment: I am officially registered but will probably never be able to get over to the actual conference, given all the meetings I have pre-scheduled. Others report 75% of their time in pre-scheduled off-site meetings, and the other 25% in random encounters at the convention itself, or the many hospitality suites and receptions sponsored by major attendees.
And that is the name-of-the game—the conference has gotten so large that you can't count on running into all the people whom you want to meet with…so you schedule meetings and meeting locations well before you arrive.
For those who never get to the conference, it's common to have well over 20 meetings scheduled, and for some companies it's far more. Networking related to potential deals and actual deals are the dominant theme of most meetings.
And for others who couldn't nab an official entry badge, just hanging out in the lobby of the St. Francis guarantees valuable networking and an opportunity for random encounters with many colleagues whom you haven't seen in some time.
Many business development/ licensing executives report that the JP Morgan Health Care Conference is the only financial conference they attend—the other conferences on their "always" list are the Bio Conferences and the Annual LES Conference.
Other premier banking health care conferences mentioned include-UBS, Merrill Lynch, Alex Brown, and Cowen, as well as major business development conferences.
All in all, the JP Morgan Health Care Conference remains at the top of the list; and although it's well recognized that the conference has outgrown the facilities of the St. Francis, no one wants to break the traditional venue. So see you again the first full week in January 2009 at the 27th Annual JP Morgan Health Care Conference for the beginning of another fabulous year of deals and financing.
Viewpoints Archive Articles
January 2008
Private Equity Comes To Biotech
Executive Summary/IN VIVO: The Business & Medicine Report 08-07
By Roger Longman
>>Read Article
November 2007
2007 Deals of Distinction Awarded At Annual Meeting
Global BioPharma Deals
Come Full Circle
By Al Rickard
>>Read Article
August 2007
Decision Making Confirmed By Neuroeconomics
By Linda M. Pullan, Ph.D.
>>Read Article
April 2007
Reality Check: What Has Pharma Really Been Paying
For Alliances?
By Mark Edwards, Managing Director, Recombinant Capital Inc.
>>Read Article
January 2007
From Licensing To M&A: A Stepped Up Challenge For
L&BD
By Ed Saltzman
>>Read Article
October 2006
2006 Deals of Distinction Awarded At Annual Meeting
By Al Rickard
Biotech-Biotech
Portfolio Deal
>>Read Article
August 2006
The Business Development Paradox: Why Big Pharma Needs Biotech’s
Compounds…and Biotech Needs Big Pharma’s
By Roger Longman
>>Read Article
|